Fungal metabolites as pharmaceuticals
Natural products, their derivatives or compounds based on natural product leads constitute ∼50% of clinically used pharmaceuticals. This review highlights pharmaceuticals currently used in Australia and New Zealand that have their origins in fungal meta
|Collections||ANU Research Publications|
|Source:||Australian Journal of Chemistry|
|01_Beekman_Fungal_metabolites_as_2014.pdf||3.27 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.